Combining designer receptors exclusively activated by designer drugs and neuroimaging in experimental models: A powerful approach towards neurotheranostic applications - Peeters - 2020 - British Journal of Pharmacology - Wiley Online Library
An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects - ScienceDirect
New Technologies for Elucidating Opioid Receptor Function: Trends in Pharmacological Sciences
![PDF] DREADDs for Neuroscientists | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cc7db00617d97220b2f596e27279d1b9ea9bcf59/2-Table1-1.png "PDF] DREADDs for Neuroscientists | Semantic Scholar")
PDF] DREADDs for Neuroscientists | Semantic Scholar
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect
Ligand and G-protein selectivity in the κ-opioid receptor | Nature
![PDF] DREADDs for Neuroscientists | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cc7db00617d97220b2f596e27279d1b9ea9bcf59/6-Figure3-1.png "PDF] DREADDs for Neuroscientists | Semantic Scholar")
PDF] DREADDs for Neuroscientists | Semantic Scholar
Kappa-opioid receptor stimulation in the nucleus accumbens shell: Differential effects across the rostro-caudal axis on dopamine transmission and affective behavior | bioRxiv
Behavioral and Physiological Effects of a Novel Kappa-Opioid Receptor-Based DREADD in Rats | Neuropsychopharmacology
Modulating Dopamine Signaling and Behavior with Chemogenetics: Concepts, Progress, and Challenges | Pharmacological Reviews
Usefulness of knockout mice to clarify the role of the opioid system in chronic pain - Maldonado - 2018 - British Journal of Pharmacology - Wiley Online Library
Opioid receptors: drivers to addiction? | Nature Reviews Neuroscience
Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments | eNeuro
The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice | Scientific Reports
Schematic representation of dynorphin/kappa opioid receptor system... | Download Scientific Diagram
Frontiers | The Use of DREADDs to Deconstruct Behavior
The claustrum-prelimbic cortex circuit through dynorphin/κ-opioid receptor signaling underlies depression-like behaviors associated with social stress etiology | Nature Communications
Dynorphin / kappa-opioid receptor regulation of excitation-inhibition balance toggles afferent control of prefrontal cortical circuits in a pathway-specific manner | Molecular Psychiatry
Psychoactives | Free Full-Text | The Role of the Dynorphin/Kappa Opioid Receptor System in the Actions of Alcohol
PDF) A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior
A Cre Driver Line for Genetic Targeting of Kappa Opioid Receptor Expressing Cells | eNeuro
Resolving Behavioral Output via Chemogenetic Designer Receptors Exclusively Activated by Designer Drugs | Journal of Neuroscience
![PDF] Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c7b09d4a79773b4f3d7b0fec2825409ca299dac6/5-Figure1-1.png "PDF] Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments | Semantic Scholar")